188 related articles for article (PubMed ID: 20818481)
1. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors.
Wan SB; Yang H; Zhou Z; Cui QC; Chen D; Kanwar J; Mohammad I; Dou QP; Chan TH
Int J Mol Med; 2010 Oct; 26(4):447-55. PubMed ID: 20818481
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.
Zhang W; Bai H; Han L; Zhang H; Xu B; Cui J; Wang X; Ge Z; Li R
Bioorg Med Chem Lett; 2018 Aug; 28(14):2459-2464. PubMed ID: 29886021
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.
Milacic V; Banerjee S; Landis-Piwowar KR; Sarkar FH; Majumdar AP; Dou QP
Cancer Res; 2008 Sep; 68(18):7283-92. PubMed ID: 18794115
[TBL] [Abstract][Full Text] [Related]
4. A New Water-Soluble Nanomicelle Formed through Self-Assembly of Pectin-Curcumin Conjugates: Preparation, Characterization, and Anticancer Activity Evaluation.
Bai F; Diao J; Wang Y; Sun S; Zhang H; Liu Y; Wang Y; Cao J
J Agric Food Chem; 2017 Aug; 65(32):6840-6847. PubMed ID: 28721737
[TBL] [Abstract][Full Text] [Related]
5. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.
Banerjee S; Ji C; Mayfield JE; Goel A; Xiao J; Dixon JE; Guo X
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8155-8160. PubMed ID: 29987021
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells.
Zhou B; Zuo Y; Li B; Wang H; Liu H; Wang X; Qiu X; Hu Y; Wen S; Du J; Bu X
Mol Cancer Ther; 2013 Aug; 12(8):1381-92. PubMed ID: 23696216
[TBL] [Abstract][Full Text] [Related]
7. Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction.
Bonfili L; Pettinari R; Cuccioloni M; Cecarini V; Mozzicafreddo M; Angeletti M; Lupidi G; Marchetti F; Pettinari C; Eleuteri AM
ChemMedChem; 2012 Nov; 7(11):2010-20. PubMed ID: 22997162
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: from ancient medicine to current clinical trials.
Hatcher H; Planalp R; Cho J; Torti FM; Torti SV
Cell Mol Life Sci; 2008 Jun; 65(11):1631-52. PubMed ID: 18324353
[TBL] [Abstract][Full Text] [Related]
9. Clinical development of novel proteasome inhibitors for cancer treatment.
Yang H; Zonder JA; Dou QP
Expert Opin Investig Drugs; 2009 Jul; 18(7):957-71. PubMed ID: 19505187
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological assessment of novel N-(hydroxy/methoxy)alkyl β-enaminone curcuminoids.
Theppawong A; De Vreese R; Vannecke L; Grootaert C; Van Camp J; D'hooghe M
Bioorg Med Chem Lett; 2016 Dec; 26(23):5650-5656. PubMed ID: 27843113
[TBL] [Abstract][Full Text] [Related]
11. Improving the anticancer activity of curcumin using nanocurcumin dispersion in water.
Basniwal RK; Khosla R; Jain N
Nutr Cancer; 2014; 66(6):1015-22. PubMed ID: 25068616
[TBL] [Abstract][Full Text] [Related]
12. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
[TBL] [Abstract][Full Text] [Related]
13. New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells.
Padhye S; Yang H; Jamadar A; Cui QC; Chavan D; Dominiak K; McKinney J; Banerjee S; Dou QP; Sarkar FH
Pharm Res; 2009 Aug; 26(8):1874-80. PubMed ID: 19421843
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.
Zhang J; Cao J; Xu L; Zhou Y; Liu T; Li J; Hu Y
Bioorg Med Chem; 2014 Jun; 22(11):2955-65. PubMed ID: 24767818
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethylcellulose-tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin.
Plyduang T; Lomlim L; Yuenyongsawad S; Wiwattanapatapee R
Eur J Pharm Biopharm; 2014 Oct; 88(2):351-60. PubMed ID: 24859389
[TBL] [Abstract][Full Text] [Related]
16. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines.
Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S
Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828
[TBL] [Abstract][Full Text] [Related]
17. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
Liu L; Fu Y; Zheng Y; Ma M; Wang C
Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
[TBL] [Abstract][Full Text] [Related]
19. Curcumin and cancer: barriers to obtaining a health claim.
Devassy JG; Nwachukwu ID; Jones PJ
Nutr Rev; 2015 Mar; 73(3):155-65. PubMed ID: 26024538
[TBL] [Abstract][Full Text] [Related]
20. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review.
Slika L; Patra D
Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
